This article reviews the literature on some of the available biomarkers such as p53 and its down-stream effector p21 on superficial bladder tumor biology and their prognostic significance. The role of p53 tumor suppressor gene is controversial in superficial bladder cancer, possibly because analyzing one single effector of a pathway might hide the role of downstream effectors. The aggressiveness of this condition is related to proliferative activity as measured by Ki-67. Further studies are still necessary to draw definitive conclusions about the role of these different biological markers in superficial bladder cancer.SCOPUS: re.jinfo:eu-repo/semantics/publishe
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
In predicting the aggressive behavior of bladder tumors, the histopathological characteristics of gr...
The study was undertaken to compare the levels of p53, bcl-2, and Ki-67 in 40 patients who had under...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
The International Consensus Panel on cytology and bladder tumor markers evaluated markers that have ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Contains fulltext : 47399schalken.pdf (publisher's version ) (Closed access)The In...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Introduction: Urinary bladder cancer is one of the common genitourinary malignancy presenting to the...
The search for molecular markers that will permit the opti-mized individual management of patients w...
Immunohistochemical examination of microvascular density can be an additional prognostic factor in p...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
In predicting the aggressive behavior of bladder tumors, the histopathological characteristics of gr...
The study was undertaken to compare the levels of p53, bcl-2, and Ki-67 in 40 patients who had under...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
The International Consensus Panel on cytology and bladder tumor markers evaluated markers that have ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Contains fulltext : 47399schalken.pdf (publisher's version ) (Closed access)The In...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening ...
Introduction: Urinary bladder cancer is one of the common genitourinary malignancy presenting to the...
The search for molecular markers that will permit the opti-mized individual management of patients w...
Immunohistochemical examination of microvascular density can be an additional prognostic factor in p...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
In predicting the aggressive behavior of bladder tumors, the histopathological characteristics of gr...